All News
Filter News
Found 808,963 articles
-
Myrtelle to Host Symposium on Gene Therapies Targeting Oligodendrocytes and Implications in Brain Function and Disease States at the American Society of Gene and Cell Therapy 26th Annual Meeting
5/10/2023
Myrtelle to Host Symposium on Gene Therapies Targeting Oligodendrocytes and Implications in Brain Function and Disease States at the American Society of Gene and Cell Therapy 26th Annual Meeting in Los Angeles on Friday, May 19, 2023.
-
Twist Bioscience to Present at ITF World 2023
5/10/2023
Twist Bioscience Corporation today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at Imec Technology Forum (ITF) World 2023 in Antwerp, Belgium on Wednesday, May 17th at 11:10 AM CEST.
-
VectivBio Publishes Invitation to the Annual General Meeting - May 10, 2023
5/10/2023
VectivBio Holding AG today published the invitation to the 2023 Annual General Meeting, which will be held on Thursday, June 1, 2023, at 3:00 p.m. CEST / 9:00 a.m. EDT at Memox (meeting room "Small Space"), Elisabethenstrasse 15, 4051 Basel, Switzerland.
-
HARMONY BIOSCIENCES TO PRESENT NEW WAKIX® (PITOLISANT) SAFETY AND EFFICACY DATA AT SLEEP 2023 ANNUAL MEETING
5/10/2023
Harmony Biosciences Holdings, Inc. today announced that new safety and efficacy data from a Phase 2 proof-of-concept study evaluating pitolisant for the treatment of excessive daytime sleepiness in patients with Prader-Willi syndrome (PWS) will be highlighted as a poster presentation during a late-breaking abstract session at the 37th Annual Meeting of the Associated Professional Sleep Societies (APSS), known as "SLEEP 2023," in Indianapolis from June 3-7.
-
LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
5/10/2023
LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s first quarter 2023 financial results will be released before market open on Monday, May 15, 2023.
-
Bausch Health Observes Mental Health Awareness Month
5/10/2023
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is proud to recognize May as Mental Health Awareness Month by continuing efforts that highlight the importance of educating and supporting those with mental health care needs.
-
Actinium Pharma to Present at Guggenheim Healthcare Talks Radiopharmaceuticals Day
5/10/2023
Actinium Pharmaceuticals, Inc. today announced that the Company's management team will participate in 1x1 meetings and deliver a corporate presentation on Monday, May 15, 2023 at 3:20 PM EST at the Guggenheim Healthcare Talks Radiopharmaceuticals Day.
-
Ionis to host 2023 virtual Annual Meeting of Stockholders
5/10/2023
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2023 virtual Annual Meeting of Stockholders followed by a general corporate update on Thursday, June 1, 2023.
-
Verrica Pharmaceuticals Announces Presentation at the RBC Capital Markets Global Healthcare Conference
5/10/2023
Verrica Pharmaceuticals Inc. today announced that Ted White, Verrica President & Chief Executive Officer, will present at the upcoming RBC Capital Markets Global Healthcare Conference, which is being held at the InterContinental New York Barclay Hotel from May 16-17, 2023.
-
Zevra Therapeutics will Participate in RBC Capital Markets Global Healthcare Conference on May 16, 2023
5/10/2023
Zevra Therapeutics, Inc. today announced that R. LaDuane Clifton, the Company’s Chief Financial Officer, will present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023, at 3:05 p.m. ET.
-
Capsida Biotherapeutics to Present New Data Showing Increased Capsid Expression in CNS at American Society of Gene & Cell Therapy 26th Annual Meeting
5/10/2023
Capsida Biotherapeutics ("Capsida") today announced it will present preliminary data on the company's next-generation engineered adeno-associated virus (AAV) capsids in non-human primates.
-
ImmPACT Bio to Present at the 2023 RBC Capital Markets Global Healthcare Conference
5/10/2023
ImmPACT Bio USA , Inc. today announced that it will participate at the 2023 RBC Capital Markets Global Healthcare Conference, to be held from May 16-17, 2023.
-
Avalyn Pharma Presenting at BioEquity Europe
5/10/2023
Avalyn Pharma Inc. today announced that Lyn Baranowski , CEO, is planning to present a corporate update during the BioEquity Europe conference being held May 14-16, 2023.
-
BioAegis Therapeutics to Sponsor a Webinar, Below the Eyes of the Hippopotamus: The Expanding Spectrum of Auto- and Hyper- Inflammatory Diseases
5/10/2023
BioAegis Therapeutics, Inc. announces that it will host a free webinar on the expanding spectrum of auto- and hyper- inflammatory diseases on Tuesday, May 23, 2023 at 2:00 pm Eastern Time.
-
Virpax Pharmaceuticals To Present at Upcoming CB Tech Watch Seminar
5/10/2023
Virpax ® Pharmaceuticals, Inc. today announced that it has been invited to present its Molecular Envelope Technology (MET), as well as its AnQlar TM product candidate for viral inhibition that utilizes MET, at the June 8, 2023, virtual CB Tech Watch Seminar.
-
ADC Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
5/10/2023
ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 16th at 10:00 a.m. EDT.
-
Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
5/10/2023
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, reported financial results for the quarter ended March 31, 2023, and provided a business update.
-
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
5/10/2023
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2023, affirmed 2023 financial guidance and provided business updates.
-
New Data Published in Nature Show Envivo Bio’s Ingestible Device Provides Novel Insights Into the Human Microbiome and Metabolome
5/10/2023
Envivo Bio, a biotech company advancing the gut microbiome and metabolome field, announced that new data published in Nature show the company’s proprietary CapScan® intestinal sampling device can non-invasively and accurately profile the human gut microbiome and metabolome under physiological conditions for the first time.
-
Teknova Reports First Quarter 2023 Financial Results
5/10/2023
Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the first quarter ended March 31, 2023.